×

Business / Stock Market

Algernon completes 50% enrollment in mid-stage IPF and chronic cough study

Published May 11 2021 at 11:33 AM GMT

Seeking Alpha @seekingalpha.com

Add to Collections
Report Post

Continue reading at seekingalpha.com

Key
Points

Algernon completes 50% enrollment in mid-stage IPF and chronic cough study.

Credit

Tags

Continue reading at seekingalpha.com

Posted in Business, Stock Market

Stats

Published May 11, 2021 11:33 AM GMT